PROTAGENIC THERAPEUTICS, INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • July 2nd, 2021 • Protagenic Therapeutics, Inc.\new • Services-business services, nec • New York
Contract Type FiledJuly 2nd, 2021 Company Industry Jurisdiction